{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:45:43Z","timestamp":1793403943175,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish National Health Services (ALF-YF)"},{"name":"The Swedish Parkinson Foundation (Parkinsonfonden)"},{"name":"The Swedish Parkinson Academy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.parkreldis.2013.01.020","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T21:07:07Z","timestamp":1361567227000},"page":"407-415","source":"Crossref","is-referenced-by-count":211,"title":["Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations"],"prefix":"10.1016","volume":"19","author":[{"given":"Andreas","family":"Puschmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2013.01.020_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410400513","article-title":"Clinical genetic analysis of Parkinson's disease in the Contursi kindred","volume":"40","author":"Golbe","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410380306","article-title":"A\u00a0Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation","volume":"38","author":"Markopoulou","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9","article-title":"Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism","volume":"46","author":"Markopoulou","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.52.3.651","article-title":"Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance?","volume":"52","author":"Papadimitriou","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/mds.1221","article-title":"Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation","volume":"16","author":"Bostantjopoulou","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jnnp.70.5.662","article-title":"Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease","volume":"70","author":"Papapetropoulos","year":"2001","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10048-008-0138-0","article-title":"Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease","volume":"9","author":"Choi","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-0004.2007.00781.x","article-title":"The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease","volume":"71","author":"Ki","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.2004.046425","article-title":"A\u00a0case of late onset sporadic Parkinson's disease with an A53T mutation in alpha-synuclein","volume":"76","author":"Michell","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.parkreldis.2009.06.007","article-title":"A\u00a0Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction","volume":"15","author":"Puschmann","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.21966","article-title":"First appraisal of brain pathology owing to A30P mutant alpha-synuclein","volume":"67","author":"Seidel","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the alpha-synuclein gene (PARK 1)","volume":"310","author":"Somme","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/mds.20581","article-title":"Abnormal sleep architecture is an early feature in the E46K familial synucleinopathy","volume":"20","author":"Zarranz","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10286-010-0068-4","article-title":"Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA)","volume":"20","author":"Tijero","year":"2010","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease","volume":"364","author":"Ibanez","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/mds.22682","article-title":"Expanding the clinical phenotype of SNCA duplication carriers","volume":"24","author":"Nishioka","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.parkreldis.2008.08.002","article-title":"Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?","volume":"15","author":"Puschmann","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10048-009-0229-6","article-title":"Analysis of exon dosage using MLPA in South African Parkinson's disease patients","volume":"11","author":"Keyser","year":"2010","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib24","unstructured":"Puschmann A. Heredity in Parkinson's disease. From rare mutations to common genetic risk factors. Lund University, Faculty of Medicine Doctoral Dissertation Series. 2011;95:174."},{"key":"10.1016\/j.parkreldis.2013.01.020_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.24962","article-title":"The neuropathology of genetic Parkinson's disease","volume":"27","author":"Poulopoulos","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","article-title":"Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes","volume":"15","author":"Hasegawa","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.parkreldis.2012.03.024","article-title":"LRRK2 I2020T mutation is associated with tau pathology","volume":"18","author":"Ujiie","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10048-005-0005-1","article-title":"Lrrk2 pathogenic substitutions in Parkinson's disease","volume":"6","author":"Mata","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/01.WNL.0000172630.22804.73","article-title":"A\u00a0clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations","volume":"65","author":"Zabetian","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1212\/01.wnl.0000239829.33936.73","article-title":"LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP","volume":"67","author":"Spanaki","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.parkreldis.2008.09.001","article-title":"Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism","volume":"15","author":"Ross","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib34","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/mds.23265","article-title":"Novel pathogenic LRRK2\u00a0p.Asn1437His substitution in familial Parkinson's disease","volume":"25","author":"Aasly","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.parkreldis.2011.11.019","article-title":"First neuropathological description of a patient with Parkinson's disease and LRRK2\u00a0p.N1437H mutation","volume":"18","author":"Puschmann","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.parkreldis.2007.04.003","article-title":"Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain","volume":"13","author":"Gonzalez-Fernandez","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10048-009-0187-z","article-title":"Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain","volume":"10","author":"Mata","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.parkreldis.2008.09.002","article-title":"LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay","volume":"15","author":"Mata","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","article-title":"A\u00a0frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease","volume":"365","author":"Di Fonzo","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs","volume":"354","author":"Lesage","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","article-title":"Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations","volume":"76","author":"Kachergus","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","article-title":"Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review","volume":"16","author":"Correia Guedes","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib44","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1474-4422(11)70175-2","article-title":"Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","article-title":"Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers","volume":"77","author":"Marras","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archneur.63.3.377","article-title":"LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance","volume":"63","author":"Gaig","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib48","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/mds.21016","article-title":"Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian","volume":"21","author":"Carmine Belin","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib49","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","article-title":"Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease","volume":"70","author":"Haugarvoll","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-006-0178-1","article-title":"Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions","volume":"113","author":"D\u00e4chsel","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/gte.2008.0042","article-title":"Co-occurrence of sporadic parkinsonism and late-onset Alzheimer's disease in a Brazilian male with the LRRK2\u00a0p.G2019S mutation","volume":"12","author":"Santos-Reboucas","year":"2008","journal-title":"Genet Test"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","article-title":"Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation","volume":"7","author":"Wider","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilarino-Guell","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib54","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.parkreldis.2007.11.013","article-title":"Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family","volume":"14","author":"Wider","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A\u00a0mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib56","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e318253d5f2","article-title":"Identification of VPS35 mutations replicated in French families with Parkinson disease","volume":"78","author":"Lesage","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.10.032","article-title":"Screening for VPS35 mutations in Parkinson's disease","volume":"33","author":"Sheerin","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmedgenet-2012-101155","article-title":"A\u00a0multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants","volume":"49","author":"Sharma","year":"2012","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib59","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/mds.25145","article-title":"VPS35 mutation in Japanese patients with typical Parkinson's disease","volume":"27","author":"Ando","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib60","first-page":"1","article-title":"Frequency of the D620N mutation in VPS35 in Parkinson disease","author":"Kumar","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2012.01.006","article-title":"Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population","volume":"33","author":"Verstraeten","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib62","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.parkreldis.2012.05.002","article-title":"VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population","volume":"18","author":"Guo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib63","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10048-012-0334-9","article-title":"Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease","volume":"13","author":"Schulte","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2012.04.033","article-title":"Study of the genetic variability in a Parkinson's disease gene: EIF4G1","volume":"518","author":"Tucci","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib66","article-title":"Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia","author":"Fujioka","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.parkreldis.2004.03.009","article-title":"The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family","volume":"10","author":"Lu","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.parkreldis.2008.09.005","article-title":"Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions","volume":"15","author":"Socal","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib69","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1212\/01.wnl.0000269323.21969.db","article-title":"Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?","volume":"69","author":"Charles","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib70","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.parkreldis.2010.07.006","article-title":"FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients","volume":"16","author":"Hall","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib72","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1468-1331.2010.03107.x","article-title":"Frontotemporal dementia and parkinsonism linked to chromosome 17 \u2013 the first Polish family","volume":"18","author":"Narozanska","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1750-3639.2007.00052.x","article-title":"Hereditary frontotemporal dementia caused by tau gene mutations","volume":"17","author":"van Swieten","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib75","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib76","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(07)70221-1","article-title":"Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C\u2192T (Arg493X) mutation: an international initiative","volume":"6","author":"Rademakers","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2007.08.022","article-title":"Prominent phenotypic variability associated with mutations in progranulin","volume":"30","author":"Kelley","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10048-011-0288-3","article-title":"Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia","volume":"12","author":"Quadri","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib79","article-title":"TARDBP mutations in Parkinson's disease","author":"Rayaprolu","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.parkreldis.2007.12.010","article-title":"A\u00a0new mutation in the GCH1 gene presents as early-onset Parkinsonism","volume":"15","author":"Momma","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib82","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1468-1331.2006.01249.x","article-title":"Low frequency of parkin, tyrosine hydroxylase, and GTP cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease","volume":"13","author":"Hertz","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jmg.2005.039149","article-title":"The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations","volume":"43","author":"Sharma","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.05.024","article-title":"Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease","volume":"32","author":"Sharma","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","article-title":"Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study","volume":"364","author":"Luoma","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib86","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archneur.64.4.553","article-title":"Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism","volume":"64","author":"Hudson","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib87","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ana.20831","article-title":"Early-onset familial parkinsonism due to POLG mutations","volume":"59","author":"Davidzon","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib88","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.parkreldis.2008.01.009","article-title":"Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene","volume":"14","author":"Remes","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jns.2011.10.006","article-title":"Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity","volume":"314","author":"Sundal","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib90","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1212\/WNL.0b013e3181a826c0","article-title":"Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?","volume":"72","author":"Wider","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ng.1027","article-title":"Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids","volume":"44","author":"Rademakers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp.2009.204081","article-title":"Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family","volume":"82","author":"Boxer","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib93","first-page":"1749","article-title":"Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype?","volume":"259","author":"Floris","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib94","first-page":"9999","article-title":"Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease","author":"Lindquist","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib95","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.23.3.239","article-title":"Paralysis agitans of early onset with marked diurnal fluctuation of symptoms","volume":"23","author":"Yamamura","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib97","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib98","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.parkreldis.2007.10.003","article-title":"Parkin analysis in early onset Parkinson's disease","volume":"14","author":"Sironi","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib99","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.parkreldis.2009.06.010","article-title":"Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease","volume":"16","author":"Koziorowski","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2007.11.016","article-title":"Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia","volume":"15","author":"Mellick","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib101","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib102","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.parkreldis.2009.09.010","article-title":"Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease","volume":"15","author":"Ahlskog","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib103","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/mds.25132","article-title":"Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease","volume":"27","author":"Kilarski","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib104","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.20384","article-title":"Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report","volume":"20","author":"Suzuki","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib105","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib106","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib107","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib108","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.10675","article-title":"The role of pathogenic DJ-1 mutations in Parkinson's disease","volume":"54","author":"Abou-Sleiman","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib109","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/humu.20089","article-title":"Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)","volume":"24","author":"Hering","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.20666","article-title":"DJ-1 mutations and parkinsonism\u2013dementia\u2013amyotrophic lateral sclerosis complex","volume":"58","author":"Annesi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib111","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/humu.9240","article-title":"Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: parkin mutation frequency depends on ethnic origin of patients","volume":"23","author":"Djarmati","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib112","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.10613","article-title":"How much phenotypic variation can be attributed to parkin genotype?","volume":"54","author":"Lohmann","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib113","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A\u00a0wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib114","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.63.4.548","article-title":"Case-control study of the parkin gene in early-onset Parkinson disease","volume":"63","author":"Clark","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","article-title":"Deciphering the role of heterozygous mutations in genes associated with parkinsonism","volume":"6","author":"Klein","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib116","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/mds.22996","article-title":"Clinical spectrum of Kufor\u2013Rakeb syndrome in the Chilean kindred with ATP13A2 mutations","volume":"25","author":"Behrens","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib117","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib118","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation","volume":"25","author":"Schneider","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib119","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1399-0004.2011.01745.x","article-title":"Novel mutation in ATP13A2 widens the spectrum of Kufor\u2013Rakeb syndrome (PARK9)","volume":"82","author":"Eiberg","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib120","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib121","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archneurol.2010.281","article-title":"Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype","volume":"67","author":"Bruggemann","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib122","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mds.23552","article-title":"Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib123","article-title":"Novel SPG11 mutations in Chinese families with hereditary spastic paraplegia with thin corpus callosum","author":"Cao","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib124","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia\u2013parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","article-title":"R632W mutation in PLA2G6 segregates with dystonia\u2013parkinsonism in a consanguineous Iranian family","volume":"16","author":"Sina","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib127","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","article-title":"Neurodegeneration associated with genetic defects in phospholipase A(2)","volume":"71","author":"Gregory","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib128","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","article-title":"Widespread Lewy body and tau accumulation in childhood and adult onset dystonia\u2013parkinsonism cases with PLA2G6 mutations","volume":"33","author":"Paisan-Ruiz","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib129","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ajhg.2008.05.005","article-title":"Genome-wide linkage analysis of a parkinsonian-pyramidal syndrome pedigree by 500\u00a0K SNP arrays","volume":"82","author":"Shojaee","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib130","doi-asserted-by":"crossref","first-page":"e36458","DOI":"10.1371\/journal.pone.0036458","article-title":"A\u00a0deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism","volume":"7","author":"Edvardson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib131","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","author":"K\u00f6ro\u011flu","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib132","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","article-title":"Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study","volume":"67","author":"Alcalay","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib133","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/WNL.52.9.1876","article-title":"Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group","volume":"52","author":"Elbaz","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib134","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ajhg.2008.01.015","article-title":"Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease","volume":"82","author":"Lautier","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib135","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/01.wnl.0000346517.98982.1b","article-title":"Variation in GIGYF2 is not associated with Parkinson disease","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib136","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/mds.22640","article-title":"GIGYF2 variants are not associated with Parkinson's disease in Italy","volume":"24","author":"Bonetti","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib137","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/ddn340","article-title":"Lack of replication of association between GIGYF2 variants and Parkinson disease","volume":"18","author":"Bras","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib138","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.parkreldis.2009.05.001","article-title":"GIGYF2 mutations are not a frequent cause of familial Parkinson's disease","volume":"15","author":"Di Fonzo","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib139","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00439-009-0678-x","article-title":"Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations","volume":"126","author":"Tan","year":"2009","journal-title":"Hum Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.22451","article-title":"Reported mutations in GIGYF2 are not a common cause of Parkinson's disease","volume":"24","author":"Vilarino-Guell","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib141","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.parkreldis.2009.01.005","article-title":"PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease","volume":"15","author":"Zimprich","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib142","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib143","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.parkreldis.2008.08.003","article-title":"Genetic variation of Omi\/HtrA2 and Parkinson's disease","volume":"14","author":"Ross","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib144","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/hmg\/ddn096","article-title":"Sequencing analysis of OMI\/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls","volume":"17","author":"Simon-Sanchez","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"548","key":"10.1016\/j.parkreldis.2013.01.020_bib145","first-page":"e9","article-title":"A\u00a0large-scale genetic association study to evaluate the contribution of Omi\/HtrA2 (PARK13) to Parkinson's disease","volume":"32","author":"Kruger","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.01.020_bib146","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T07:25:21Z","timestamp":1714980321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1353802013000552"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.01.020","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}